Objectives. To compare the effectiveness of a steroid injection (25 mg/ml prednisolone acetate) with a local anaesthetic control in the treatment of heel pain and to determine any advantage for patients' comfort of using a posterior tibial nerve block to anaesthetize the heel prior to infiltration.
Patients with plantar heel pain commonly present in beneficial or detrimental treatment effects difficult to estimate. Three randomized evaluations of steroid injecrheumatology clinics and general medical practice. The aetiology is poorly understood, but is believed to be tions have either reached conflicting conclusions about their superiority in relation to heel cups and orthoses partly inflammatory and partly biomechanical. It has been suggested that patients' occupations and lifestyles [10, 11] or shown similar cure rates using injected saline [12] . [1] , body mass indices [2] , biomechanical characteristics [3] and the duration of the pain [4] are involved in the There are drawbacks in injecting the heel with steroids: mainly rupture of the plantar fascia and atrophy of the aetiology and can affect the outcome.
In common with other musculoskeletal conditions, fat pad [1, 13] . In an observational study, Acevido and Beskin [14] reported a plantar fascial rupture rate of steroid injections have been used to treat plantar heel pain since the 1950s [5] and are one of the most 10% in patients after steroid injection for heel pain. Another drawback is the extreme pain experienced by frequently described treatments for painful heels in the medical literature [6 ] . In a survey of orthopaedic sursome patients during an infiltration of the tissues surrounding the calcaneum. geons, 73% reported using steroids to treat painful heels [7] . Rheumatologists also regularly administer this This paper reports a double-blind randomized controlled trial of steroid injection used to treat plantar therapy; as a prelude to this study, 100 randomly selected consultant rheumatologists were sent a questionnaire to heel pain. The aim of this study was to produce evidence of the effectiveness of one steroid injection for plantar assess their current management of heel pain. Steroid injections were the most frequently reported treatment, heel pain using local anaesthetic as a control, and to assess the value of administering a tibial nerve block to often in conjunction with heel pads, ultrasound and stretching exercises.
improve patient comfort and pain outcomes. Systematic reviews evaluating steroids for painful shoulders and elbows show that evidence of effectiveness Method is scant [8, 9] . Robust evaluations using randomized, double-blind designs are rare for painful heels, making
The trial was conducted between January 1995 and December 1998. After ethical committee approval, general practitioners (GPs) and rheumatologists in Camden Hospital, the site of the trial. Patients with a clinical diagnosis of heel pain were invited to participate if they efficacy between the two allocations to be identified with 80% confidence. reported pain and tenderness centred on the medial Treatment allocation was concealed from both the tubercle of the calcaneum on weight bearing after rest clinician (DA) who took all outcome measurements and which resolved, either partly or fully, after activity. the physician (JE ) who administered all injections, by Patients using orthoses, insoles, pads or analgesia were an independent observer (FC ) who was responsible also included and not advised to discontinue these for the treatment allocation. The independent observer therapies. After verbal and written information, all also prepared the injections and, in order to obscure included patients gave written consent.
the syringe contents from the physician and patients, Patients were excluded from the study if they were masked the syringes using white dressing tape. An empty pregnant, under the age of 18 yr, had received a steroid syringe was used to aspirate the injection site before it injection for heel pain within the previous 6 months, was disconnected, leaving the needle in situ; the masked were receiving anticoagulants or were unable to give syringe containing the allocated treatment was then consent.
connected to the needle. Only the clinician taking outPatients were allocated to one of four interventions come measurements was blind to the administration of using a computer-generated randomization schedule the tibial nerve block. The codes for the allocation stratified to ensure equal numbers of participants in schedule were known only to the independent observer each group. The unit of randomization was individual and were held in file by the departmental secretary. The episodes of heel pain. The four interventions were: (A) code was broken at the end of the trial. 1 ml of 25 mg/ml of prednisolone acetate with 1 ml of 2% lignocaine; (B) 1 ml of 25 mg/ml of prednisolone acetate with 1 ml of 2% lignocaine given after a tibial Results nerve block; (C ) 2 ml of 1% lignocaine hydrochloride;
One hundred and six patients with heel pain entered the (D) 2 ml of 1% lignocaine hydrochloride given after a trial; 69 females and 37 males. The age range was tibial nerve block.
30-87 yr, the mean age was 57 yr (± 12.9). The range All heels were infiltrated through the medial aspect of heel pain duration for all trial participants was 1-120 of the heel pad. In order to assess the accuracy of months, the median duration was 6 months (± 20.6). placement, a small sample of patients had MRI to
The mean pain score of patients at the time of entry to confirm needle position. Five cases were assessed using the trial was 5.7 (± 2.4). Table 1 shows baseline characa dedicated, small-part low-field-strength MRI scanner.
teristics for trial patients analysed at group level. Only In those five, the tip of the needle was confirmed to be two patients had been diagnosed with seronegative within the body of the flexor digitorum brevis muscle pathology. just deep to the heel fascia and immediately distal to its origin from the calcaneus.
Primary outcomes
The mean pre-treatment pain scores and mean pain Primary outcomes scores at 1, 3 and 6 months are presented in Table 2 .
The comparison of outcomes at 1 month shows a Ten-centimetre visual analogue scales were used for all statistical difference in favour of treatment with steroid primary outcomes. Patients who met the inclusion (P = 0.02). No statistically significant difference in pain criteria were asked to score their level of heel pain at reduction could be detected between the injected subthe time of entry to the trial. Participants immediately stances for pain outcomes taken at 3 and 6 months; the received treatment according to the random allocation, P values were 0.9 and 0.8, respectively. after which they were asked to score the degree of pain
The number of patients lost to follow-up at 1 month from the heel injection. Outcome measurements were was 4%. This rose to 25% at 3 months and by 6 months taken at 1, 3 and 6 months post-treatment to measure was 48% (51 patients). No statistical difference existed pain in the treated heel. At the termination of the trial, in the numbers of patients lost to follow-up between the all participating patients were sent a questionnaire to four groups (P = 0.7), but made an intention-to-treat determine whether they were cured by the trial treatment analysis impractical. allocation, had sought further treatment for heel pain Sixty-two patients returned end of trial questionnaires, from a different health provider (e.g. GP) and whether 38 (75%) of them were patients for whom the outcome they still suffered from heel pain. at 6 months was unknown. Nineteen of those still had heel pain and 16 had sought treatment from other health Prognostic variables care providers. These outcomes did not differ signifiData were collected about the duration of heel pain, cantly from those patients with known 6 month outweight, height [body mass index (BMI )], occupation comes; 11 patients still had heel pain and nine sought (sedentary or active) and the presence of Helbing's sign treatment elsewhere. Thus, 28% of the entire trial popu-(a soft-tissue indication of excessive subtalar joint lation reported having heel pain at the end of the trial. pronation).
Prognostic variables An a priori power calculation indicated that 90 patients randomized to receive either steroid or a local A regression analysis did not detect a relationship between the duration of heel pain and pain scores at anaesthetic control would allow a 30% difference in Local anaesthetic (LA) alone 5.5 ± 2.1 4.0 ± 2.9 3.7 ± 3.3 3.3 ± 2.7 n = 27 Corticosteroid and LA+tibial nerve block 5.5 ± 2.1 4.5 ± 2.6 3.4 ± 2.7 2.5 ± 3.2 n = 26 Corticosteroid and LA 5.6 ± 2.3 2.9 ± 2.5 3.6 ± 2.8 2.4 ± 2.6 n = 27 Local anaesthetic + tibial nerve block 5.8 ± 2.8 5.3 ± 2.9 3.1 ± 2.7 0.6 ± 1.1 n = 26 aP = 0.02; bP = 0.9; cP = 0.8.
1 month (P = 0.3). The patients' perception of pain excessive subtalar joint pronation. According to these findings, patients' heel pain does not benefit from weight from the steroid injection did not appear to be significantly altered by the prior administration of tibial nerve loss or prompt treatment after the onset of symptoms. Indeed, it was not possible to distinguish any features block (P = 0.5). No statistical differences in pain scores were detected between patients who had their heel associated with a good or poor outcome. The pain perceived by patients at the time of injection anaesthetized and those who did not (P = 0.5). No relationship was found between BMI and pain reduction did not differ between those who had a tibial nerve block and those who did not, and there seems to be at 1 month (P = 0.6).
Pain and sedentary or active occupations did not no value in undertaking this additional procedure to increase patient comfort or improve outcomes. There appear to be associated (P = 0.6), nor was a relationship apparent between patients' age and pain (P = 0.3).
are two possible explanations for this conclusion. The first is that direct contact with the nerve during the Twenty-five per cent of participants had a positive Helbing's sign, indicating excessive subtalar joint pronaadministration of the anaesthetic can occur and is painful. The second is the variable success in achieving tion, but no relationship was found to exist between pain reduction and the presence or absence of Helbing's anaesthesia of the posterior tibial nerve in a relatively short period of time (out-patient appointment). sign (P = 0.3). Thirteen per cent of participants wore insoles at entry to the trial, but no relationship
The large loss to follow-up at the 6 month outcome reduced the trial's power and it is not possible to make was detected between insole wearing and pain scores (P = 0.2).
valid statistical conclusions about the efficacy of the treatment at 6 months, but the outcomes are reported for completeness.
Discussion
Of the 52% of trial patients who did document pain scores at 6 months ( Table 2) , the reductions in pain The comparability of baseline characteristics (age, duration of pain and initial pain scores) of patients in each were uniform across all four intervention groups, suggesting that, for half of the trial patients, the condition group indicates that the randomization procedure was successful ( Table 1 ). The range of participants' ages resolved naturally over time. From patients' responses to the end of trial questionnaire, it is clear that for 28% reflects the findings of non-randomized studies of the condition [15] [16] [17] and there can be little doubt that the natural history of the condition was not one of improvement. plantar heel pain predominantly affects adults, often in mid to late life.
Reductions in patients' pain scores were significantly greater in the two arms that received steroid at 1 month, The analysis did not detect any relationship between pain reduction and patient characteristics. Patients' age, but at 3 months no therapeutic advantage could be detected. The short-term nature of the benefit from BMI, occupation and the duration of their pain prior to treatment did not seem to be associated with their steroid injections has previously been reported in the treatment of painful shoulders [8] and in observational outcome nor did the use of orthoses or the presence of tematic review of treatments for the painful heel. studies of painful heels [5, 18] 
